RLMD (Relmada Therapeutics) Short Interest


RLMD Relmada Therapeutics Inc RLMD
29 GF Score
Price $6.67
! 2 Warning Signs
View Full Analysis

What is Relmada Therapeutics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

RLMD vs ALLO, PHAT, AURA: Short Interest Comparison

For the Biotechnology subindustry, Relmada Therapeutics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Relmada Therapeutics Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Relmada Therapeutics's Short Interest distribution charts can be found below:

* The bar in red indicates where Relmada Therapeutics's Short Interest falls into.


RLMD
29GF Score
Relmada Therapeutics Inc RLMD
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Relmada Therapeutics Business Description

Other Exchanges 4E2:Germany
Address 2222 Ponce de Leon Boulevard, Floor 3, Coral Gables, FL, USA, 33134
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.
29GF Score

Get the complete analysis for RLMD

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.67
Price